Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0

NCT04045717 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.

NCT NCT04045717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04045717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Phase
Phase 2
Overall status
Active, not recruiting
Start date
April 10, 2020
Completion date
February 16, 2032
Enrollment
124 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma, prostate cancer, prostate neoplasm